Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06612034
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-21
Brief Title:
Prostate Cancer Care Disparity Analysis Project ProGAP
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluating the Worldwide Landscape of Prostate Cancer Management
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This international cross-sectional study seeks to evaluate global disparities in prostate cancer management by conducting a thorough comparison of key elements across countries categorized as low-income lower-middle-income upper-middle-income and high-income
The primary question it addresses is Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide To achieve this we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications Participants will complete a 17-question online survey
The primary question it addresses is Are the standards of care for prostate cancer uniformly applied across different geographic regions worldwide To achieve this we will recruit physicians specializing in the diagnosis and treatment of prostate cancer from a diverse array of countries within these income classifications Participants will complete a 17-question online survey
Detailed Description:
Prostate cancer stands as one of the most common cancers among men worldwide with outcomes and care quality significantly varying due to a multitude of factors including geographic location healthcare infrastructure socioeconomic status and clinical practices The ProGAP project is conceived to delve into these variations providing a detailed examination of the global landscape of prostate cancer care
Objectives
1 To systematically gather and analyze data on current diagnostic methods treatment modalities and management practices for prostate cancer from a wide range of countries and healthcare settings
2 To identify and quantify disparities in access to and availability of standard care novel treatments and supportive services for patients with prostate cancer
3 To evaluate the adherence levels to both international and national guidelines in prostate cancer treatment across diverse healthcare systems
Methods
The ProGAP survey will be distributed internationally to healthcare professionals including urologists uro-oncologists medical oncologists and radiation oncologists who are actively involved in prostate cancer care The survey will comprehensively cover demographic details clinical practice environment patient demographics and stages managed guideline adherence availability and use of diagnostic and treatment options and multidisciplinary care approaches A survey and a consent form will be sent to study participants in addition to written information about the study Completing surveys will take 10-12 minutes Participants will complete a 17-question online survey The first part of the form includes questions about demographics and hospital characteristics The second part contains questions about prostate cancer diagnosis treatment and management practices Participation in this study is entirely voluntary and anonymous Neither sensitive personal data nor contact information will be collected during the research This research does not receive any specific grant from funding agencies in the public commercial or not-for-profit sectors and the investigators declare that they do not have any conflict of interest with the work
Data Analysis Plan
Statistical analyses will employ both descriptive and inferential statistics to interpret the survey data Comparative analyses will be conducted to uncover disparities across different regions and healthcare settings Advanced statistical methods such as regression analysis may be utilized to explore factors associated with variations in care practices and outcomes
Expected Impact
By elucidating the disparities in prostate cancer care worldwide ProGAP aims to stimulate policy changes guide improvements in clinical practice and foster international collaborations to enhance the quality of care and outcomes for patients with prostate cancer globally Insights gained from this project are anticipated to inform stakeholders including healthcare providers policymakers and patient advocacy groups about critical areas for intervention and improvement
Objectives
1 To systematically gather and analyze data on current diagnostic methods treatment modalities and management practices for prostate cancer from a wide range of countries and healthcare settings
2 To identify and quantify disparities in access to and availability of standard care novel treatments and supportive services for patients with prostate cancer
3 To evaluate the adherence levels to both international and national guidelines in prostate cancer treatment across diverse healthcare systems
Methods
The ProGAP survey will be distributed internationally to healthcare professionals including urologists uro-oncologists medical oncologists and radiation oncologists who are actively involved in prostate cancer care The survey will comprehensively cover demographic details clinical practice environment patient demographics and stages managed guideline adherence availability and use of diagnostic and treatment options and multidisciplinary care approaches A survey and a consent form will be sent to study participants in addition to written information about the study Completing surveys will take 10-12 minutes Participants will complete a 17-question online survey The first part of the form includes questions about demographics and hospital characteristics The second part contains questions about prostate cancer diagnosis treatment and management practices Participation in this study is entirely voluntary and anonymous Neither sensitive personal data nor contact information will be collected during the research This research does not receive any specific grant from funding agencies in the public commercial or not-for-profit sectors and the investigators declare that they do not have any conflict of interest with the work
Data Analysis Plan
Statistical analyses will employ both descriptive and inferential statistics to interpret the survey data Comparative analyses will be conducted to uncover disparities across different regions and healthcare settings Advanced statistical methods such as regression analysis may be utilized to explore factors associated with variations in care practices and outcomes
Expected Impact
By elucidating the disparities in prostate cancer care worldwide ProGAP aims to stimulate policy changes guide improvements in clinical practice and foster international collaborations to enhance the quality of care and outcomes for patients with prostate cancer globally Insights gained from this project are anticipated to inform stakeholders including healthcare providers policymakers and patient advocacy groups about critical areas for intervention and improvement
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None